Cargando…

Combining Sanford Arylations on Benzodiazepines with the Nuisance Effect

5‐Phenyl‐1,3‐dihydro‐2H‐1,4‐benzodiazepin‐2‐ones react under palladium‐ and visible light photoredox catalysis, in refluxing methanol, with aryldiazonium salts to afford the respective 5‐(2‐arylphenyl) analogues. With 2‐ or 4‐fluorobenzenediazonium derivatives, both fluoroaryl‐ and methoxyaryl‐ prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Raysa, Boonseng, Sarote, Kemmitt, Paul D., Felix, Robert, Coles, Simon J., Tizzard, Graham J., Williams, Gareth, Simmonds, Olivia, Harvey, Jessica‐Lily, Atack, John, Cox, Hazel, Spencer, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079647/
https://www.ncbi.nlm.nih.gov/pubmed/30100832
http://dx.doi.org/10.1002/adsc.201700626
Descripción
Sumario:5‐Phenyl‐1,3‐dihydro‐2H‐1,4‐benzodiazepin‐2‐ones react under palladium‐ and visible light photoredox catalysis, in refluxing methanol, with aryldiazonium salts to afford the respective 5‐(2‐arylphenyl) analogues. With 2‐ or 4‐fluorobenzenediazonium derivatives, both fluoroaryl‐ and methoxyaryl‐ products were obtained, the latter resulting from a S(N)Ar on the fluorobenzenediazonium salt (“nuisance effect”). A computational DFT analysis of the palladium‐catalysed and the palladium/ruthenium‐photocalysed mechanism for the functionalization of benzodiazepines indicated that, in the presence of the photocatalyst, the reaction proceeds via a low‐energy SET pathway avoiding the high‐energy oxidative addition step in the palladium‐only catalysed reaction pathway. [Image: see text]